157 related articles for article (PubMed ID: 20740345)
1. Prognostic importance of neuroendocrine differentiation in Japanese breast cancer patients.
Sawaki M; Yokoi K; Nagasaka T; Watanabe R; Kagawa C; Takada H; Sato S; Yamada T; Kikumori T; Imai T; Nakao A
Surg Today; 2010 Sep; 40(9):831-5. PubMed ID: 20740345
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine-like differentiation in patients with pancreatic carcinoma.
Tezel E; Nagasaka T; Nomoto S; Sugimoto H; Nakao A
Cancer; 2000 Dec; 89(11):2230-6. PubMed ID: 11147593
[TBL] [Abstract][Full Text] [Related]
3. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.
Kasprzak A; Zabel M; Biczysko W
Pol J Pathol; 2007; 58(1):23-33. PubMed ID: 17585539
[TBL] [Abstract][Full Text] [Related]
4. Expression of neuroendocrine differentiation markers in lethal metastatic castration-resistant prostate cancer.
Sainio M; Visakorpi T; Tolonen T; Ilvesaro J; Bova GS
Pathol Res Pract; 2018 Jun; 214(6):848-856. PubMed ID: 29728311
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine differentiation and prognosis in breast adenocarcinoma.
Miremadi A; Pinder SE; Lee AH; Bell JA; Paish EC; Wencyk P; Elston CW; Nicholson RI; Blamey RW; Robertson JF; Ellis IO
Histopathology; 2002 Mar; 40(3):215-22. PubMed ID: 11895486
[TBL] [Abstract][Full Text] [Related]
6. Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer.
Makretsov N; Gilks CB; Coldman AJ; Hayes M; Huntsman D
Hum Pathol; 2003 Oct; 34(10):1001-8. PubMed ID: 14608533
[TBL] [Abstract][Full Text] [Related]
7. Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer.
Ather MH; Abbas F; Faruqui N; Israr M; Pervez S
BMC Urol; 2008 Dec; 8():21. PubMed ID: 19115997
[TBL] [Abstract][Full Text] [Related]
8. [Neuroendocrine carcinoma of breast: a study of tumor morphology and subtyping].
Gao LX; Liu G; Li L; Lin HY; Jin H; Cheng J; Jin ML; Ding HY
Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):604-9. PubMed ID: 22177244
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer.
Carles J; Rosell R; Ariza A; Pellicer I; Sanchez JJ; Fernandez-Vasalo G; Abad A; Barnadas A
Lung Cancer; 1993 Dec; 10(3-4):209-19. PubMed ID: 7521264
[TBL] [Abstract][Full Text] [Related]
10. Correlation between chromogranin A, neuron-specific enolase and synaptophysin expression, and some clinico-pathological features of colorectal cancer.
Famulski W; Sulkowska M; Miller-Famulska D; Kisielewski W; Sulkowski S
Folia Histochem Cytobiol; 2001; 39(2):155-6. PubMed ID: 11374802
[TBL] [Abstract][Full Text] [Related]
11. HER-2/neu cytoplasmic staining is correlated with neuroendocrine differentiation in breast carcinoma.
Horiguchi S; Hishima T; Hayashi Y; Shiozawa Y; Horiguchi K; Kuroi K; Toi M; Funata N; Eishi Y
J Med Dent Sci; 2010 Jun; 57(2):155-63. PubMed ID: 21073134
[TBL] [Abstract][Full Text] [Related]
12. [Research on the relationship between non-small cell lung cancer with neuroendocrine differentiation and the biological characteristics and prognosis].
Zhang J; Zheng K; Guo Y; Zhang P; Zhan Z
Zhongguo Fei Ai Za Zhi; 2010 Sep; 13(9):873-6. PubMed ID: 20840816
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 induces neuroendocrine differentiation (NED) through suppression of RE-1 silencing transcription factor (REST).
Zhu Y; Liu C; Cui Y; Nadiminty N; Lou W; Gao AC
Prostate; 2014 Aug; 74(11):1086-94. PubMed ID: 24819501
[TBL] [Abstract][Full Text] [Related]
14. Neuron-Specific Enolase as an Immunohistochemical Marker Is Better Than Its Reputation.
Mjønes P; Sagatun L; Nordrum IS; Waldum HL
J Histochem Cytochem; 2017 Dec; 65(12):687-703. PubMed ID: 28972818
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine Differentiation in Metastatic Conventional Prostate Cancer Is Significantly Increased in Lymph Node Metastases Compared to the Primary Tumors.
Genitsch V; Zlobec I; Seiler R; Thalmann GN; Fleischmann A
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28788048
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic study of breast cancer with features of endocrine ductal carcinoma-in-situ].
Yang WT; Xu YX; Zhang TQ
Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):594-7. PubMed ID: 17134566
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of neuroendocrine components in gastric carcinomas.
Park JY; Ryu MH; Park YS; Park HJ; Ryoo BY; Kim MG; Yook JH; Kim BS; Kang YK
Eur J Cancer; 2014 Nov; 50(16):2802-9. PubMed ID: 25201164
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine differentiation correlates with hormone receptor expression and decreased survival in patients with invasive breast carcinoma.
Kwon SY; Bae YK; Gu MJ; Choi JE; Kang SH; Lee SJ; Kim A; Jung HR; Kang SH; Oh HK; Park JY
Histopathology; 2014 Apr; 64(5):647-59. PubMed ID: 24117859
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and prognostic significance of acinar cell differentiation in pancreatic endocrine tumors.
Yantiss RK; Chang HK; Farraye FA; Compton CC; Odze RD
Am J Surg Pathol; 2002 Jul; 26(7):893-901. PubMed ID: 12131156
[TBL] [Abstract][Full Text] [Related]
20. Is neuroendocrine differentiation a prognostic factor in poorly differentiated colorectal cancer?
Chen Y; Liu F; Meng Q; Ma S
World J Surg Oncol; 2017 Mar; 15(1):71. PubMed ID: 28351413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]